Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early antibiotic eradication of Pseudomonas aeruginosa in cystic fibrosis: two randomized protocols
2008-006502-42Phase 4Active
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Apr 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cystic fibrosis (CF) and Pseudomonas aeruginosa airway infection comparing Ciprofloxacin + inhaled tobramycin with Ciprofloxacin + inhaled colistin (2 arms). Primary endpoint: Primary effectiveness of eradication treatment. Started Apr 2010; status: active.
02
Drugs
tobramycincolistinciprofloxacin
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa airway infection
Beyond the preview
Go deeper on 2008-006502-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006502-42.